USANA Health Sciences, Inc. (NYSE:USNA – Get Free Report) Director John Turman Fleming sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $44.43, for a total transaction of $44,430.00. Following the sale, the director now owns 2,503 shares of the company’s stock, valued at $111,208.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
USANA Health Sciences Trading Down 2.9 %
Shares of NYSE USNA opened at $43.32 on Friday. The firm has a 50 day moving average of $45.71 and a 200 day moving average of $46.81. The firm has a market capitalization of $825.25 million, a price-to-earnings ratio of 13.50, a price-to-earnings-growth ratio of 1.49 and a beta of 0.90. USANA Health Sciences, Inc. has a 12-month low of $40.51 and a 12-month high of $67.32.
USANA Health Sciences (NYSE:USNA – Get Free Report) last posted its quarterly earnings results on Tuesday, July 23rd. The company reported $0.54 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.11). The firm had revenue of $212.87 million during the quarter, compared to the consensus estimate of $218.64 million. USANA Health Sciences had a return on equity of 11.13% and a net margin of 6.29%. During the same quarter in the previous year, the company earned $0.89 earnings per share. Sell-side analysts predict that USANA Health Sciences, Inc. will post 2.5 EPS for the current year.
Hedge Funds Weigh In On USANA Health Sciences
Wall Street Analyst Weigh In
Several analysts recently issued reports on the stock. StockNews.com lowered shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. DA Davidson cut their target price on shares of USANA Health Sciences from $46.00 to $38.00 and set a “neutral” rating for the company in a research report on Thursday, July 25th.
Read Our Latest Analysis on USANA Health Sciences
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Articles
- Five stocks we like better than USANA Health Sciences
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Generac Raises Guidance: Why Is the Stock Still a Hold?
- What are earnings reports?
- Iconic Burger Chain’s Stock Rallies, Defying Market Trends
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- First Solar Stock: The Dawn of a New Rally in Share Prices
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.